Home »
Academic Articles »
Art »
Healthy lifestyle attenuates the clonal hematopoiesis-associated coronary artery disease risk
Healthy lifestyle attenuates the clonal hematopoiesis-associated coronary artery disease risk
Yuxin Yang
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China)
Xuxiang Shen
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China)
Keyong Huang
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China)
Hongwei Liu
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China)
Jianxin Li
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China)
Fangchao Liu
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China)
Shufeng Chen
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China)
Jie Cao
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China)
Hongfan Li
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China)
Xiaoqing Liu
(Division of Epidemiology, Guangdong Provincial People’s Hospital and Cardiovascular Institute, Guangzhou 510080, China)
Chong Shen
(Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
Ling Yu
(Department of Cardiology, Fujian Provincial Hospital, Fuzhou 350014, China)
Dongsheng Hu
(Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou 450001, China; Department of Biostatistics and Epidemiology, School of Public Health, Shenzhen University Health Science Center, Shenzhen 518071, China)
Jianfeng Huang
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China)
Tong Wang
(Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan 030001, China)
Wenjing Tian
(Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150081, China)
Dongfeng Gu
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China; School of Public Health and Emergency Management, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China)
Xiangfeng Lu
(Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China; Corresponding author.)
Journal: Fundamental Research
•
• KeAi Communications Co. Ltd.
• ISSN: 2667-3258
Abstract
Lifestyle factors and clonal hematopoiesis of indeterminate potential (CHIP) both contribute to the risk of developing coronary artery disease (CAD), but whether a healthy lifestyle could attenuate CHIP-related CAD risk is unknown. A total of 6113 participants from the Prediction for Atherosclerotic Cardiovascular Disease Risk in China project were included. Lifestyle was categorized as unfavorable, intermediate, and favorable according to the number of healthy lifestyle factors (body mass index, smoking, sleep, physical activity, and diet). CHIP mutations were detected by targeted deep sequencing (mean depth, 916 ×). After a median follow-up of 12.1 years, 760 cases of CAD were recorded. A favorable lifestyle and CHIP were associated with 53% lower (HR (hazard ratio) = 0.47; 95% CI (confidence interval): 0.36–0.61) and 41% higher (HR = 1.41; 95% CI: 1.17–1.72) CAD risk, respectively. Of note, the elevated CAD risk attributed to CHIP was found in the intermediate (HR = 1.48; 95% CI: 1.03–2.11) and unfavorable (HR = 1.57; 95% CI: 1.22–2.01) lifestyle groups, but not in the favorable (HR = 0.71; 95% CI: 0.36–1.42) group. Unfavorable lifestyle and CHIP jointly contributed to a 2.78-fold increased risk of CAD (95% CI: 1.95–3.97) compared with non-CHIP carriers with a favorable lifestyle, indicating a significant additive interaction between CHIP and lifestyle (RERI (relative excess risk due to interaction) = 1.08; 95% CI: 0.40–1.77). Specifically, the protective effect of lifestyle depends on the size of cell fractions, with an intermediate lifestyle mitigating CAD risk in small clone carriers (VAF (variant allele fraction): 0.5%-2%), and a favorable lifestyle being necessary for common clone carriers (VAF ≥ 2%). In summary, CHIP carriers exhibited a higher risk of CAD, while a favorable lifestyle could attenuate the excess risk related to CHIP. Efforts should be made to promote intensive behavioral interventions among CHIP carriers.